Transportation to and from cancer centers for outpatient cancer treatments has been identified as one of the two most impactful out-of-pocket costs that cancer patients and their families incur, along with food…




Transportation to and from cancer centers for outpatient cancer treatments has been identified as one of the two most impactful out-of-pocket costs that cancer patients and their families incur, along with food…


Biomedical innovation reached a new era during the COVID-19 pandemic as drug development went into overdrive. But the ways that brand companies license their patented drugs grant them market monopoly, preventing other…


Although virtual health care has been on the horizon for years, telehealth use exploded in the early days of the coronavirus disease 2019 (COVID-19) pandemic: It increased by more than 4,000 percent…


Non-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had worse outcomes compared to non-Hispanic whites, Asians, and Hispanics, despite similar 21-gene recurrence scores, according to a study presented at…


Drug overdose deaths among pregnant and postpartum women increased more than 180 percent in the past five years, according to a new study conducted at Columbia University Mailman School of Public Health.…
Preventing metastasis – the development of cancer cells beyond their original location – remains one of the major goals of current cancer research. Most malignant tumor cells metastasize by exploiting abnormal leakage…


Key takeaways White researchers have been consistently funded by the National Science Foundation at higher rates than most nonwhite researchers since at least 1999. From 1999 to 2019, proposals by white applicants…


A Rice University laboratory, with a boost from the Bill & Melinda Gates Foundation,will develop a once-a-year treatment for patients infected with HIV and other infectious diseases. The Rice lab of bioengineer Omid Veiseh has received a…


Women were underrepresented in COVID-19 treatment clinical trials, and some racial and ethnic groups were underrepresented in COVID-19 prevention trials, according to a new meta-analysis conducted by Fred Hutchinson Cancer Center in collaboration with…